| Name | (E)-1-(4-acetylpiperazin-1-yl)-3-[3-nitro-4-(2-propan-2-ylphenyl)sulfanylphenyl]prop-2-en-1-one |
|---|---|
| Synonyms | unii-5i8wfs075a |
| Description | A-286982 is a potent and allosteric LFA-1/ICAM-1 interaction inhibitor with IC50s of 44 nM and 35 nM in an LFA-1/ICAM-1 binding and LFA-1-mediated cellular adhesion assay, respectively[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 44 nM (LFA-1/ICAM-1 interaction in an LFA-1/ICAM-1 binding assay) and 35 nM (LFA-1/ICAM-1 interaction in LFA-1-mediated cellular adhesion assay)[1] |
| In Vitro | A-286982 binds to the I domain allosteric site (IDAS). The allosteric ICAM inhibition such as this would be expected to exhibit the unsurmountable competition we have observed for A-286982 as a result of the passage of this allostery through the A-286982 binding site in its transmission from the β subunit I-like domain to the α subunit ICAM binding site[2]. |
| References |
| Molecular Formula | C24H27N3O4S |
|---|---|
| Molecular Weight | 453.55400 |
| Exact Mass | 453.17200 |
| PSA | 111.74000 |
| LogP | 4.97230 |
| Storage condition | -20°C |
| RIDADR | NONH for all modes of transport |
|---|